[The clinical experience with MARS and Prometheus procedures].
Based on the hypothesis, that extracorporeal removal of endo- and egzogenic substances should be beneficial to the clinical course of the patient in liver failure or poisoned, treatment systems were evaluatedbased on the two concepts: (1) blood dialysis against albumin dialysate--Molecular Adsorbent Recirculating System (MARS), Single Pass Albumin Dialysis (SPAD), Continuous Veno-Venous Haemodiafiltration (CWHDF); (2) selective albumin filtration and adsorption combined with haemodialysis--Fractioned Plasma Separation and Adsorption-Prometheus. We present our own experiences with MARS and Prometheus procedures between 2003-2006 years.
Hydzik
Piotr
P
Oddział (Kliniczny) Toksyklogii i Chorób Srodowiskowych, WSS im. L. Rydygiera w Krakowie. piodzik@poczta.onet.pl
Gawlikowski
Tomasz
T
Ciszowski
Krzysztof
K
Sułlek
Monika
M
D000327:Adsorption; D005060:Europe; D005112:Extracorporeal Circulation / Q000295:instrumentation*; D005240:Feasibility Studies; D006440:Hemofiltration / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D017114:Liver Failure, Acute / Q000378:metabolism / Q000628:therapy*; D016031:Liver Transplantation; D019164:Liver, Artificial; D008567:Membranes, Artificial; D006435:Renal Dialysis / Q000379:methods; D012709:Serum Albumin / Q000378:metabolism; D016896:Treatment Outcome
D008567:Membranes, Artificial; D012709:Serum Albumin